{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:50:12Z","timestamp":1790992212379,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jns.2024.123023","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:54:38Z","timestamp":1714492478000},"page":"123023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of lipid-lowering therapy on carotid plaque burden in older adults"],"prefix":"10.1016","volume":"461","author":[{"given":"Stella","family":"Iankov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Sikand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram Arsang","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mojtaba","family":"Sohrevardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Hackam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Reza","family":"Azarpazhooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2024.123023_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcdd6020019","article-title":"Cardiovascular risks associated with gender and aging","volume":"6","author":"Rodgers","year":"2019","journal-title":"J. Cardiovasc. Develop. and Disease."},{"issue":"9841","key":"10.1016\/j.jns.2024.123023_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet (London, England)."},{"issue":"1","key":"10.1016\/j.jns.2024.123023_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2020.7848","article-title":"Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older","volume":"324","author":"Orkaby","year":"2020","journal-title":"Jama"},{"issue":"20","key":"10.1016\/j.jns.2024.123023_bb0020","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.117.028271","article-title":"Primary prevention with statin therapy in the elderly: new meta-analyses from the contemporary JUPITER and HOPE-3 randomized trials","volume":"135","author":"Ridker","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2024.123023_bb0025","first-page":"685","article-title":"A prospective study of pravastatin in the elderly at risk (PROSPER)","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.jns.2024.123023_bb0030","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.jns.2024.123023_bb0035","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.2019.1676","article-title":"Reexamining recommendations for treatment of hypercholesterolemia in older adults","volume":"321","author":"Skolnik","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jns.2024.123023_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.atherosclerosis.2015.07.033","article-title":"The ACC\/AHA 2013 pooled cohort equations compared to a Korean risk prediction model for atherosclerotic cardiovascular disease","volume":"242","author":"Jung","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jns.2024.123023_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacc.2020.05.016","article-title":"Association of statin use with disability-free survival and cardiovascular disease among healthy older adults","volume":"76","author":"Zhou","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.jns.2024.123023_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002497","article-title":"Overcoming challenges with statin therapy","volume":"5","author":"Spence","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.jns.2024.123023_bb0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jcmg.2012.03.013","article-title":"Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the high risk plaque BioImage study","volume":"5","author":"Sillesen","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"11","key":"10.1016\/j.jns.2024.123023_bb0060","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jacc.2015.01.017","article-title":"Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study","volume":"65","author":"Baber","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.jns.2024.123023_bb0065","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.STR.0000042207.16156.B9","article-title":"Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy","volume":"33","author":"Spence","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123023_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cccb.2021.100004","article-title":"Measurement of carotid plaque burden: a tool for predicting and preventing dementia?","volume":"2","author":"Shin","year":"2021","journal-title":"Cerebral Circulation - Cognition and Behavior."},{"issue":"1","key":"10.1016\/j.jns.2024.123023_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the advisory board of the 3rd and 4th watching the risk symposium, 13th and 15th European stroke conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc. Dis."},{"issue":"11","key":"10.1016\/j.jns.2024.123023_bb0080","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/STROKEAHA.107.487264","article-title":"Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromso study","volume":"38","author":"Johnsen","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2024.123023_bb0085","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/STROKEAHA.110.589754","article-title":"Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromso study","volume":"42","author":"Mathiesen","year":"2011","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.jns.2024.123023_bb0090","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.STR.0000042207.16156.B9","article-title":"Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy","volume":"33","author":"Spence","year":"2002","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2024.123023_bb0095","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.echo.2021.12.016","article-title":"Reliability, reproducibility and advantages of measuring carotid total plaque area","volume":"35","author":"Azarpazhooh","year":"2022","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.jns.2024.123023_bb0100","author":"Fund; UNP"},{"issue":"12","key":"10.1016\/j.jns.2024.123023_bb0105","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1161\/STROKEAHA.120.031707","article-title":"Stroke prevention in older adults: recent advances","volume":"51","author":"Spence","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123023_bb0110","unstructured":"National Institute for Health and Care Excellence (NICE). Cardiovascular disease: risk assessment and reduction, including lipid modification NG238 [Internet]. London. NICE; 2023 [updated 2023 Dec 14; cited 2024 May 2]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng238."},{"issue":"10170","key":"10.1016\/j.jns.2024.123023_bb0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"Armitage","year":"2019","journal-title":"Lancet"},{"issue":"9326","key":"10.1016\/j.jns.2024.123023_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial","volume":"360","author":"Group HPSC","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2024.123023_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cccb.2021.100004","article-title":"Measurement of carotid plaque burden: a tool for predicting and preventing dementia?","volume":"2","author":"Shin","year":"2021","journal-title":"Cerebral Circulation-Cognition and Behavior."},{"issue":"15","key":"10.1016\/j.jns.2024.123023_bb0130","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/CIRCULATIONAHA.118.036846","article-title":"Trust the blinded randomized evidence that statin therapy rarely causes symptomatic side effects","volume":"138","author":"Peto","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jns.2024.123023_bb0135","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.jns.2024.123023_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCOUTCOMES.109.868299","article-title":"The JUPITER trial: results, controversies, and implications for prevention","volume":"2","author":"Ridker","year":"2009","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"9756","key":"10.1016\/j.jns.2024.123023_bb0145","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek atorvastatin and coronary heart disease evaluation (GREACE) study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet (London, England)."},{"issue":"1","key":"10.1016\/j.jns.2024.123023_bb0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1559-4572.2008.07967.x","article-title":"High-dose atorvastatin after stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) Investigators","volume":"3","author":"Karam","year":"2008","journal-title":"J. Cardiometab. Syndr."},{"issue":"2","key":"10.1016\/j.jns.2024.123023_bb0155","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/STROKEAHA.110.594101","article-title":"Previous statin use is not associated with an increased prevalence or degree of gradient-echo lesions in patients with acute ischemic stroke or transient ischemic attack","volume":"42","author":"Day","year":"2011","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jns.2024.123023_bb0160","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1161\/STROKEAHA.117.017358","article-title":"Use of statins and outcomes in intracerebral hemorrhage patients","volume":"48","author":"Siddiqui","year":"2017","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2024.123023_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2014.12.018","article-title":"Statins and cataracts: reverse causality?","volume":"31","author":"Spence","year":"2015","journal-title":"Can. J. Cardiol."},{"issue":"3","key":"10.1016\/j.jns.2024.123023_bb0170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000503105","article-title":"Association between use of statin and risk of dementia: a meta-analysis of observational studies","volume":"54","author":"Poly","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2024.123023_bb0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fnagi.2020.00154","article-title":"Telmisartan and Rosuvastatin synergistically ameliorate dementia and cognitive impairment in older hypertensive patients with apolipoprotein E genotype","volume":"12","author":"Hu","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2024.123023_bb0180","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","year":"2003","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jns.2024.123023_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008546","article-title":"Statin use and adverse effects among adults> 75 years of age: insights from the patient and provider assessment of lipid management (PALM) registry","volume":"7","author":"Nanna","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jns.2024.123023_bb0190","author":"Spence, J. David"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24001588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24001588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:29:58Z","timestamp":1736184598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24001588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"alternative-id":["S0022510X24001588"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123023","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of lipid-lowering therapy on carotid plaque burden in older adults","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123023"}}